Skip to main content

Pharmacogenomics is the study of how genes affect a person’s response to drugs. This field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications that can be prescribed based on a person’s genetic makeup.

Overview

Pharmacogenomics is the study of how genes affect a person’s response to drugs. This field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications that can be prescribed based on a person’s genetic makeup.

Many drugs that are currently available are “one size fits all,” but they don't work the same way for everyone. It can be difficult to predict who will benefit from a medication, who will not respond at all, and who will experience negative side effects (called adverse drug reactions). Adverse drug reactions are a significant cause of hospitalizations and deaths in the United States. 

Researchers are learning how variants in genes affect the body’s response to medications. These genetic differences will be used to predict whether a medication will be effective for a particular person and which dose will help prevent adverse drug reactions. Conditions that affect a person’s response to certain drugs include clopidogrel resistance, warfarin sensitivity, warfarin resistance, malignant hyperthermia, Stevens-Johnson syndrome/toxic epidermal necrolysis, and thiopurine S-methyltransferase deficiency.

The field of pharmacogenomics is growing, and new approaches are under study in clinical trials. In the future, pharmacogenomics will be used to develop tailored drugs to treat a wide range of health problems, including cardiovascular disease, Alzheimer's disease, cancer, and asthma.

Patient picks for Understanding genetics

Related patient information and medicines

Weight loss injection research survey

Patient information leaflet

Weight loss injection research survey

We’re running a short research survey to better understand people’s experiences, views, and information needs around weight loss injections, sometimes referred to as weight loss jabs. These medicines are increasingly discussed in the UK, but experiences of access, use, and support vary widely. The aim of this survey is to gather real-world insight.

Subconjunctival haemorrhage

Patient information leaflet

Subconjunctival haemorrhage

A subconjunctival haemorrhage is one common cause of a red eye. It is caused by a small bleed behind the covering of the eye. It can look alarming but it usually causes no symptoms and is usually harmless. The redness usually clears within two weeks. What is a subconjunctival haemorrhage. Subconjunctival haemorrhage: "Red eye" Subconjunctival.

Rhabdomyosarcoma

Patient information leaflet

Rhabdomyosarcoma

A rhabdomyosarcoma is a type of soft tissue sarcoma. Rhabdomyosarcomas grow in the muscles of the body. Rhabdomyosarcomas can occur at any age but are much more common in children and only rarely affect adults. The treatments for rhabdomyosarcomas include surgery, chemotherapy or radiotherapy, or a combination of all three. Surgery may be used on.

Calcium pyrophosphate deposition

Patient information leaflet

Calcium pyrophosphate deposition

Calcium pyrophosphate is a substance produced in the cartilages of the joints. It can become deposited as crystals on joint tissues. This is called calcium pyrophosphate deposition. Calcium pyrophosphate deposition can cause a number of problems of which the most well known is pseudogout. This is almost identical to gout, causing attacks of pain.

Leukaemia

Patient information leaflet

Leukaemia

Leukaemia is a cancer of blood-forming cells. There are different types of leukaemia. If you develop leukaemia it is important to know what type it is. This is because the outlook (prognosis) and treatments vary for the different types. What is leukaemia. Leukaemia is a cancer of cells in the bone marrow (the cells which develop into white blood.

Proctalgia fugax and anal pain

Patient information leaflet

Proctalgia fugax and anal pain

Proctalgia fugax is a fleeting pain in the anus. It lasts less than 20 minutes, with no symptoms whatsoever in between episodes. Levator ani syndrome is a pain which lasts for longer. Both are only diagnosed when no other cause is found. What is proctalgia fugax. Proctalgia fugax is one of a number of conditions which cause anal or rectal pain.

Further reading and references

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.